Skip to main content

Unified Protocol for Treatment of Depression

  • Chapter
  • First Online:
The Massachusetts General Hospital Guide to Depression

Part of the book series: Current Clinical Psychiatry ((CCPSY))

  • 1499 Accesses

Abstract

Numerous cognitive-behavioral treatment manuals have been developed to treat specific psychiatric disorders. Although these treatments are generally effective for those specific conditions, there remains a great need for interventions that can be flexibly applied across many disorders and symptoms due to high comorbidity rates and significant barriers to clinician training in distinct evidence-based psychological treatments. The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP) is a cognitive-behavioral treatment designed to treat neuroticism, a core temperamental factor that underlies the development and maintenance of emotional disorders (i.e., anxiety, depressive, and related disorders). In this chapter, we discuss the rationale for and conceptualization of the UP and its eight treatment modules. Since its development, the UP has garnered significant research support. As such, we detail findings from relevant research focused on treating depressive disorders and other related conditions. Finally, we describe each UP treatment module in depth and how providers can utilize the UP in their practice with patients with depression. Overall, the UP is a promising intervention that can be utilized across emotional disorders, including depression, and may be an intervention that is advantageous for widespread dissemination.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Brown TA, Barlow DH. Anxiety and related disorders interview schedule for DSM-5, adult and lifetime version: clinician manual. New York: Oxford University Press; 2013.

    Google Scholar 

  2. Bentley KH, Gallagher MW, Carl JR, Barlow DH. Development and validation of the Overall Depression Severity and Impairment Scale (ODSIS). Psychol Assess. 2014;26(3):815–30.

    Article  Google Scholar 

  3. Norman SB, Hami-Cissell S, Means-Christensen AJ, Stein MB. Development and validation of an Overall Anxiety Severity and Impairment Scale (OASIS). Depress Anxiety. 2006;23(4):245–9.

    Article  Google Scholar 

  4. Beck AT, Steer RA, Brown GK. Beck depression inventory-II. San Antonio. 1996;78(2):490–8.

    Google Scholar 

  5. Meyer TJ, Miller ML, Metzger RL, Borkovec TD. Development and validation of the Penn State Worry Questionnaire. Behav Res Ther. 1990;28(6):487–95.

    Article  CAS  Google Scholar 

  6. Mattick RP, Clarke JC. Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. Behav Res Ther. 1998;36(4):455–70.

    Article  CAS  Google Scholar 

  7. Peters L. Discriminant validity of the Social Phobia and Anxiety Inventory (SPAI), the Social Phobia Scale (SPS) and the Social Interaction Anxiety Scale (SIAS). Behav Res Ther. 2000;38(9):943–50.

    Article  CAS  Google Scholar 

  8. Behar E, Alcaine O, Zuellig AR, Borkovec TD. Screening for generalized anxiety disorder using the Penn State Worry Questionnaire: a receiver operating characteristic analysis. J Behav Ther Exp Psychiatry. 2003;34(1):25–43.

    Article  Google Scholar 

  9. Barlow DH, Farchione TJ, Fairholme CP, Ellard KK, Boisseau CL, Allen LB, et al. Unified protocol for transdiagnostic treatment of emotional disorders: therapist guide. New York: Oxford University Press; 2011.

    Google Scholar 

  10. Barlow DH, Farchione TJ, Sauer-Zavala S, Latin HM, Ellard KK, Bullis JR, et al. Unified protocol for transdiagnostic treatment of emotional disorders: therapist guide. 2nd ed. New York: Oxford University Press; 2018.

    Google Scholar 

  11. Boswell JF. Intervention strategies and clinical process in transdiagnostic cognitive–behavioral therapy. Psychotherapy (Chic). 2013;50(3):381.

    Article  Google Scholar 

  12. Barlow DH, Sauer-Zavala S, Carl JR, Bullis JR, Ellard KK. The nature, diagnosis, and treatment of neuroticism: back to the future. Clin Psychol Sci. 2014;2(3):344–65.

    Article  Google Scholar 

  13. Bullis JR, Barlow DH. The unified protocol for transdiagnostic treatment of emotional disorders: a progress report. Clin Psychol. 2016;3(68):4–15.

    Google Scholar 

  14. Sauer-Zavala S, Cassiello-Robbins C, Ametaj AA, Wilner JG, Pagan D. Transdiagnostic treatment personalization: the feasibility of ordering Unified Protocol modules according to patient strengths and weaknesses. Behav Modif. 2018. https://doi.org/10.1177/0145445518774914.

  15. Sauer-Zavala S, Cassiello-Robbins C, Conklin LR, Bullis JR, Thompson-Hollands J, et al. Isolating the unique effects of the Unified Protocol treatment modules using single case experimental design. Behav Modif. 2017;41(2):286–307.

    Article  Google Scholar 

  16. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602.

    Article  Google Scholar 

  17. Brown TA, Barlow DH. Comorbidity among anxiety disorders: implications for treatment and DSM-IV. J Consult Clin Psychol. 1992;60(6):835.

    Article  CAS  Google Scholar 

  18. Kessler RC, Nelson CB, Mcgonagle KA, Liu J, Swartz M, Blazer DG. Comorbidity of Dsm-iii-r major depressive disorder in the general population. Br J Psychiatry. 1996;168(30S):17–30.

    Article  Google Scholar 

  19. Fava M, Rankin MA, Wright EC, Alpert JE, Nierenberg AA, Pava J, et al. Anxiety disorders in major depression. Compr Psychiatry. 2000;41(2):97–102.

    Article  CAS  Google Scholar 

  20. Brown TA, Campbell LA, Lehman CL, Grisham JR, Mancill RB. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol. 2001;110(4):585.

    Article  CAS  Google Scholar 

  21. Andrews G, Stewart G, Morris-Yates A, Holt P, Henderson S. Evidence for a general neurotic syndrome. Br J Psychiatry. 1990;157(1):6–12.

    Article  CAS  Google Scholar 

  22. Andrews G. Comorbidity and the general neurotic syndrome. Br J Psychiatry Suppl. 1996 Jun;30:76–84.

    Article  Google Scholar 

  23. Tyrer P. Classification of neurosis. Chichester: Wiley; 1989.

    Google Scholar 

  24. Barlow DH. Unraveling the mysteries of anxiety and its disorders from the perspective of emotion theory. Am Psychol. 2000;55(11):1247.

    Article  CAS  Google Scholar 

  25. Barlow DH, Allen LB, Choate ML. Toward a unified treatment for emotional disorders. Behav Ther. 2004;35(2):205–30.

    Article  Google Scholar 

  26. Brown TA, Chorpita BF, Barlow DH. Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect, and autonomic arousal. J Abnorm Psychol. 1998;107(2):179.

    Article  CAS  Google Scholar 

  27. Brown TA. Temporal course and structural relationships among dimensions of temperament and DSM-IV anxiety and mood disorder constructs. J Abnorm Psychol. 2007;116(2):313.

    Article  Google Scholar 

  28. Brown TA, Barlow DH. A proposal for a dimensional classification system based on the shared features of the DSM-IV anxiety and mood disorders: implications for assessment and treatment. Psychol Assess. 2009;21(3):256.

    Article  Google Scholar 

  29. Griffith JW, Zinbarg RE, Craske MG, Mineka S, Rose RD, Waters AM, Sutton JM. Neuroticism as a common dimension in the internalizing disorders. Psychol Med. 2010;40(7):1125–36.

    Article  CAS  Google Scholar 

  30. Kessler RC, Cox BJ, Green JG, Ormel J, McLaughlin KA, Merikangas KR, et al. The effects of latent variables in the development of comorbidity among common mental disorders. Depress Anxiety. 2011;28(1):29–39.

    Article  Google Scholar 

  31. Kasch KL, Rottenberg J, Arnow BA, Gotlib IH. Behavioral activation and inhibition systems and the severity and course of depression. J Abnorm Psychol. 2002;111(4):589.

    Article  Google Scholar 

  32. Brown TA, Rosellini AJ. The direct and interactive effects of neuroticism and life stress on the severity and longitudinal course of depressive symptoms. J Abnorm Psychol. 2011;120(4):844.

    Article  Google Scholar 

  33. Clark LA, Watson D. Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol. 1991;100(3):316.

    Article  CAS  Google Scholar 

  34. Goldberg SB, Tucker RP, Greene PA, Davidson RJ, Wampold BE, Kearney DJ, et al. Mindfulness-based interventions for psychiatric disorders: a systematic review and meta-analysis. Clin Psychol Rev. 2018;59:52–60.

    Article  Google Scholar 

  35. Boswell JF, Conklin LR, Oswald JM, Bugatti M. The Unified Protocol for major depressive disorders. In: Farchione TJ, Barlow DH, editors. Applications of the unified protocol for transdiagnostic treatment of emotional disorders. New York: Oxford University Press; 2018. p. 67–85.

    Google Scholar 

  36. Boswell JF, Anderson LM, Barlow DH. An idiographic analysis of change processes in the unified transdiagnostic treatment of depression. J Consult Clin Psychol. 2014;82(6):1060.

    Article  Google Scholar 

  37. Boswell JF, Bugatti M. An exploratory analysis of the impact of specific interventions: some clients reveal more than others. J Couns Psychol. 2016;63(6):710.

    Article  Google Scholar 

  38. Hague B, Scott S, Kellett S. Transdiagnostic CBT treatment of co-morbid anxiety and depression in an older adult: single case experimental design. Behav Cogn Psychother. 2015;43(1):119.

    Article  Google Scholar 

  39. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–70.

    Article  CAS  Google Scholar 

  40. Ellard KK, Fairholme CP, Boisseau CL, Farchione TJ, Barlow DH. Unified protocol for the transdiagnostic treatment of emotional disorders: protocol development and initial outcome data. Cogn Behav Pract. 2010;17(1):88–101.

    Article  Google Scholar 

  41. Ornelas Maia AC, Braga AA, Nunes CA, Nardi AE, Silva AC. Transdiagnostic treatment using a unified protocol: application for patients with a range of comorbid mood and anxiety disorders. Trends Psychiatry Psychother. 2013;35(2):134–40.

    Article  Google Scholar 

  42. Bullis JR, Sauer-Zavala S, Bentley KH, Thompson-Hollands J, Carl JR, Barlow DH. The unified protocol for transdiagnostic treatment of emotional disorders: preliminary exploration of effectiveness for group delivery. Behav Modif. 2015;39(2):295–321.

    Article  Google Scholar 

  43. Reinholt N, Aharoni R, Winding C, Rosenberg N, Rosenbaum B, Arnfred S. Transdiagnostic group CBT for anxiety disorders: the unified protocol in mental health services. Cogn Behav Ther. 2017;46(1):29–43.

    Article  Google Scholar 

  44. Laposa JM, Mancuso E, Abraham G, Loli-Dano L. Unified protocol transdiagnostic treatment in group format: a preliminary investigation with anxious individuals. Behav Modif. 2017;41(2):253–68.

    Article  Google Scholar 

  45. Bilek EL, Ehrenreich-May J. An open trial investigation of a transdiagnostic group treatment for children with anxiety and depressive symptoms. Behav Ther. 2012;43(4):887–97.

    Article  Google Scholar 

  46. Kovacs M. Children’s depression inventory (CDI). Toronto: Multi-Health Systems; 1992.

    Google Scholar 

  47. Farchione TJ, Fairholme CP, Ellard KK, Boisseau CL, Thompson-Hollands J, Carl JR, et al. Unified protocol for transdiagnostic treatment of emotional disorders: a randomized controlled trial. Behav Ther. 2012;43(3):666–78.

    Article  Google Scholar 

  48. Bullis JR, Fortune MR, Farchione TJ, Barlow DH. A preliminary investigation of the long-term outcome of the unified protocol for transdiagnostic treatment of emotional disorders. Compr Psychiatry. 2014;55(8):1920–7.

    Article  Google Scholar 

  49. Barlow DH, Farchione TJ, Bullis JR, Gallagher MW, Murray-Latin H, Sauer-Zavala S, et al. The unified protocol for transdiagnostic treatment of emotional disorders compared with diagnosis-specific protocols for anxiety disorders. JAMA Psychiat. 2017;74(9):875.

    Article  Google Scholar 

  50. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56.

    Article  CAS  Google Scholar 

  51. Williams JB. A structured interview guide for the Hamilton Depression Rating Scale. Arch Gen Psychiatry. 1988;45(8):742–7.

    Article  CAS  Google Scholar 

  52. Boswell JF, Bentley KH, Sauer-Zavala S, Farchione TJ, Barlow DH. Unified protocol versus single diagnosis protocols: effects on comorbid diagnoses. Paper presented at: ADAA 2016. Proceedings of the Annual Anxiety and Depression Association of American conference. Philadelphia; 2016.

    Google Scholar 

  53. Ornelas Maia AC, Nardi AE, Cardoso A. The utilization of unified protocols in behavioral cognitive therapy in transdiagnostic group subjects: a clinical trial. J Affect Disord. 2015;172:179–83.

    Article  Google Scholar 

  54. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4(6):561–71.

    Article  CAS  Google Scholar 

  55. Ito M, Horikoshi M, Kato N, Oe Y, Fujisato H, Nakajima S, et al. Transdiagnostic and transcultural: pilot study of unified protocol for depressive and anxiety disorders in Japan. Behav Ther. 2016;47(3):416–30.

    Article  Google Scholar 

  56. Ehrenreich-May J, Kennedy SM, Sherman JA, Bilek EL, Buzzella BA, Bennett SM, et al. Unified protocols for transdiagnostic treatment of emotional disorders in children and adolescents: therapist guide. New York: Oxford University Press; 2017.

    Google Scholar 

  57. Trosper SE, Buzzella BA, Bennett SM, Ehrenreich JT. Emotion regulation in youth with emotional disorders: implications for a unified treatment approach. Clin Child Fam Psychol Rev. 2009;12(3):234–54.

    Article  Google Scholar 

  58. Ehrenreich JT, Goldstein CR, Wright LR, Barlow DH. Development of a unified protocol for the treatment of emotional disorders in youth. Child Fam Behav Ther. 2009;31(1):20–37.

    Article  Google Scholar 

  59. Ehrenreich-May J, Rosenfield D, Queen AH, Kennedy SM, Remmes CS, Barlow DH. An initial waitlist-controlled trial of the unified protocol for the treatment of emotional disorders in adolescents. J Anxiety Disord. 2017;46:46–55.

    Article  Google Scholar 

  60. Queen AH, Barlow DH, Ehrenreich-May J. The trajectories of adolescent anxiety and depressive symptoms over the course of a transdiagnostic treatment. J Anxiety Disord. 2014;28(6):511–21.

    Article  Google Scholar 

  61. Ellard KK, Bernstein EE, Hearing C, Baek JH, Sylvia LG, Nierenberg AA, et al. Transdiagnostic treatment of bipolar disorder and comorbid anxiety using the unified protocol for emotional disorders: a pilot feasibility and acceptability trial. J Affect Disord. 2017;219:209–21.

    Article  Google Scholar 

  62. Varkovitzky RL, Sherrill AM, Reger GM. Effectiveness of the unified protocol for transdiagnostic treatment of emotional disorders among veterans with posttraumatic stress disorder: a pilot study. Behav Modif. 2018;42(2):210–30.

    Article  Google Scholar 

  63. Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002;32(9):509–15.

    Article  Google Scholar 

  64. Sauer-Zavala S, Bentley KH, Wilner JG. Transdiagnostic treatment of borderline personality disorder and comorbid disorders: a clinical replication series. J Personal Disord. 2016;30(1):35–51.

    Article  Google Scholar 

  65. Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995;33(3):335–43.

    Article  CAS  Google Scholar 

  66. Bentley KH, Nock MK, Sauer-Zavala S, Gorman BS, Barlow DH. A functional analysis of two transdiagnostic, emotion-focused interventions on nonsuicidal self-injury. J Consult Clin Psychol. 2017;85(6):632.

    Article  Google Scholar 

  67. Bentley KH, Sauer-Zavala S, Cassiello-Robbins CF, Conklin LR, Vento S, Homer D. Treating suicidal thoughts and behaviors within an emotional disorders framework: acceptability and feasibility of the unified protocol in an inpatient setting. Behav Modif. 2017;41(4):529–57.

    Article  Google Scholar 

  68. Segal ZV, Williams JMG, Teasdale JD. Mind-fullness-based cognitive therapy for depression: a new approach to preventing relapse. New York: The Guilford Press; 2002.

    Google Scholar 

  69. Hayes SC, Strosahl K, Wilson KG. Acceptance and commitment therapy. New York: The Guilford Press; 1999.

    Google Scholar 

  70. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapies of depression. New York: The Guilford Press; 1979.

    Google Scholar 

  71. Ellard KK, Deckersbach T, Sylvia LG, Nierenberg AA, Barlow DH. Transdiagnostic treatment of bipolar disorder and comorbid anxiety with the unified protocol: a clinical replication series. Behav Modif. 2012;36(4):482–508.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kate H. Bentley .

Editor information

Editors and Affiliations

FAQs: Common Questions and Answers

FAQs: Common Questions and Answers

  • Q1. Multiple evidence-based treatments have been designed to treat depression (e.g., interpersonal therapy, cognitive therapy, behavioral activation, problem-solving therapy, acceptance and commitment therapy). If a clinician is trained in other treatments, in what circumstances would the UP be recommended?

  • A1. Multiple factors can be weighed in determining whether the UP would be a recommended treatment for a patient presenting with depression. If a patient has a comorbid anxiety disorder or other emotional disorder that the patient would also like to target, the UP is particularly well suited to these individuals due to its transdiagnostic approach. Similarly, if a patient presents with a desire to learn how to more adaptively respond to negative emotions and wants a treatment that focuses on emotions (rather than, say, interpersonal relationships or problems in life), the UP would be an appropriate selection. If a patient would like a structured treatment and to incorporate reading materials to better learn the skills, the UP would have an advantage over treatments for which there is not a standard patient workbook.

  • Q2. When would the UP not be recommended for a patient with depression ?

  • A2. The UP may not be recommended when a patient presents with a primary disorder that does not fit within the therapeutic framework of an “emotional disorder.” In the UP, an “emotional disorder” is conceptualized as any condition in which the functional process of experience of intense negative affect, aversive reactivity to emotion, and avoidant, maladaptive responding serves to maintain symptoms. Per this framework, prototypical emotional disorders include anxiety, depression, PTSD, OCD, and somatic symptom disorders and thus are usually appropriate to target with the UP. The UP’s emphasis on promoting more adaptive emotion management is also well suited to targeting the deficits in emotion processing and emotion dysregulation that are prominent in patients with bipolar disorder [61, 71]. Although the UP framework applies directly to the recurrent depressive episodes that are often present in bipolar disorder—as discussed throughout this chapter—additional treatment or crisis management strategies geared toward immediate mood stabilization may be indicated to directly address the (hypo) manic episodes that characterize this condition. Some eating and substance use disorders may also fit within this framework, depending on whether the functional process described above applies to the presenting individual (e.g., does the patient engage in eating disordered behavior or use alcohol/drugs primarily to relieve, suppress, or avoid unwanted emotion?). This highlights the importance of conducting a functional analysis at the start of treatment to determine whether the UP is an appropriate approach for patients presenting with a primary disorder that may or may not clearly fit within this framework. Psychotic disorders, impulsive behavioral disorders (e.g., Tourette’s), and attention-deficit hyperactivity disorder (ADHD) would generally not be appropriate to target with the UP, as these do not share the emotion-focused, mechanistic process noted above.

    A patient’s motivation for treatment is also important, and as such, if a patient prefers another evidence-based treatment modality, then that preference would generally take precedence. Patients who do not want to engage in between-session homework may prefer a treatment with less of an emphasis on homework (e.g., interpersonal therapy). Lastly, if a patient has depression that is comorbid with more extreme difficulties with emotion regulation, acute suicidality, or chronic self-harm, a more intensive and multi-modal treatment, such as dialectical behavior therapy, may be indicated; however, as previously noted, the UP has demonstrated promising results for lower-risk presentations of BPD [64].

  • Q3. A common symptom of MDD is suicidal ideation . Can that be directly addressed in the UP?

  • A3. A suicide risk assessment is an important part of diagnostic evaluation for individuals presenting with depressive symptoms. This assessment, and, if appropriate, the creation of a safety plan, typically precedes selection of treatment and, thus, the beginning of the UP. within the context of the UP, suicidal ideation can often be conceptualized as a form of emotion avoidance. Individuals who passively wish they would die (“I wish I just would not wake up”) or think about ways they could end their life may, in the short term, feel temporarily relieved by thinking about this form of escape. In the long term, however, suicidal ideation may maintain low mood and impede more healthy responses to emotional distress or generation of more adaptive solutions to problems in life. Normalization of how common suicidal ideation is in individuals with depression and that it makes sense that when someone is feeling overwhelmed or hopeless that they would consider life-ending solutions is part of starting a nonjudgmental dialogue about the role that suicidal ideation is playing in their overall experience with depression. See Bentley et al. [67] for further discussion of the UP’s approach to suicidal thoughts and behaviors.

  • Q4. How is the UP different than CBT?

  • A4. The UP is a cognitive-behavioral treatment that utilizes skills taught in other CBT manuals, and in some ways, looks functionally like other CBT interventions. Similar to other forms of CBT, clinically, the UP can also be used as a broader therapeutic “framework” rather than a structured, manualized intervention. The UP differs from most other structured CBT interventions in its transdiagnostic nature (as opposed to single-diagnosis approaches; CBT for MDD, CBT for social anxiety, CBT for OCD) and emphasis on emotion, rather than, for example, specific symptoms or situations. The UP aims to foster adaptive responses to the full range of emotions—including positive emotions, which for many patients with emotional disorders, and especially depression, may be uncomfortable to experience. Along these lines, the UP is unique from other CBT protocols in that it was designed to directly target neuroticism, a temperamental or trait-like characteristic thought to underlie a broad range of anxiety, depressive, and related disorders, rather than the surface-level symptoms of individual disorders. The UP’s modular approach, in which each module can be delivered independently, repeated, and (in some cases) reordered, is also a structural difference from many other CBT protocols.

  • Q5. How long does this treatment take to administer?

  • A5. The UP was designed to be a time-limited treatment ; however, the treatment framework and strategies can be utilized during a therapy course of any length. Most studies of the UP to date have tested the treatment when delivered in 12–20 weekly individual or group outpatient sessions; however, we have also used the UP clinically over longer courses of therapy. Our group has a variety of projects underway in which the UP is being adapted and implemented in nontraditional outpatient settings, such as partial hospital, crisis stabilization, and inpatient units, each of which requires different lengths and structures of administration (e.g., multiple daily groups, rolling admission formats). In this regard, the UP’s flexible, modular structure is advantageous as it lends itself well to a broad range of delivery formats.

  • Q6. I am interested in using the UP in my practice. How do I get started?

  • A6. The published UP, UP-A, and UP-C therapist guides and patient workbooks are available for online purchase. We have found that clinicians who are already well-versed in CBT tend to pick up the protocol easily. However, learning the nuances of the UP’s transdiagnostic, emotion-focused emphasis can be facilitated by attending UP workshops and/or receiving consultation, supervision, or program implementation services through the Unified Protocol Institute.

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bentley, K.H., Conklin, L.R., Boswell, J.F., Shapero, B.G., Olesnycky, O.S. (2019). Unified Protocol for Treatment of Depression. In: Shapero, B., Mischoulon, D., Cusin, C. (eds) The Massachusetts General Hospital Guide to Depression. Current Clinical Psychiatry. Humana Press, Cham. https://doi.org/10.1007/978-3-319-97241-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-97241-1_12

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-97240-4

  • Online ISBN: 978-3-319-97241-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics